 NEW YORK, Jan. 04, 2023 GLOBE NEWSWIRE WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential civil securities claims on behalf of shareholders of BioLineRx Ltd. NASDAQ: BLRX resulting from allegations that BioLineRx may have issued materially misleading business information to the investing public. SO WHAT: If you ... The post ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Ac... 